Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

Senescence-related epicardial adipocyte genes lead to immune infiltration and myocardial infarction progression

Dong Z., Wang L., Lang Y., Zhang R., Wang Y., Zhao C.

Prospective Study on Cardiovascular Disease, published in Front Cardiovasc Med (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Front Cardiovasc Med (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41869532
PMCID
PMC12999425
DOI
10.3389/fcvm.2026.1759091

Abstract (original English)

Background After coronary artery disease (CAD)-related myocardial injury, reactivation of the epicardium results in cardiac remodeling via paracrine secretion. However, the senescence-related genomic signature that reflects epicardial adipose tissue (EAT) and immune infiltration is not well understood. Methods Adipocyte-related differentially expressed genes (DEGs) were identified in EAT and subcutaneous adipose tissue (SAT) from patients with and without CAD. Immune cells and senescence-related DEGs in EATs were identified. A protein-protein interaction network was used to determine the hub genes. To validate these genes, a Gene Expression Omnibus (GEO) dataset investigation, single cell sequencing analysis and the validation of human sub-epicardial adipose and blood samples were performed. To investigate the mechanism, 3T3-L1 cells were used and differentiated to adipocytes and the hub genes were knocked-down and SASPs were determined. Results A Venn diagram was used to obtain 82 senescence-related DEGs, and the top 15-degree hub genes were explored. After validating using the GEO datasets and human sub-epicardial adipose samples, STAT3, SERPINE1, CDKN2A, DLG4, PTGS2, MDM2, LRP1, IRS2, PRKCD, CCND2 , and CISH were found to be significantly expressed in the group with severe CAD. The hub genes, including STAT3, MDM2, LRP1, IRS2, PRKCD, CCND2 , and CISH , were validated to be h

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research